CMPX - Compass Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$11.20
DETAILS
HIGH:
$15.00
LOW:
$9.00
MEDIAN:
$10.00
CONSENSUS:
$11.20
UPSIDE:
441.06%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 15.02 |
| Quick Ratio | 15.02 |
| Solvency Ratio | -2.852 |
| Cash Ratio | 2.19 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-12.74
Peers avg: 15.5
|
| PEG Ratio | -0.76 |
| Forward PEG | -0.76 |
| Price/Book | 4.30 |
| Price/Sales | 0.00 |
| Price/FCF | -17.22 |
| Price/Op Cash Flow | -17.23 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0448 |
| Debt/Equity | 0.0499 |
| Debt/Capital | 0.0476 |
| Long-Term Debt/Capital | 0.0429 |
| Financial Leverage | 1.12 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -3.518 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 100.1% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -71.37 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -49.14 |
| Operating Cash Flow Coverage | -5.00 |
| Capital Expenditure Coverage | -1965.72 |
| Dividend + Capital Expenditure Coverage | -1965.72 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -0.422 |
| Debt/Share | 0.0623 |
| Cash/Share | 1.32 |
| Book Value/Share | 1.25 |
| Tangible BV/Share | 1.25 |
| Equity/Share | 1.25 |
| Operating Cash Flow/Share | -0.312 |
| Capital Expenditure/Share | 0.000 |
| FCF/Share | -0.312 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.913 |
| Price/Fair Value | 4.30 |
| Debt/Market Cap | 0.0116 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -11.57 |